Laboratory investigation of METTL7A driving MSC osteogenic differentiation through YAP1 translation enhancement via eIF4F recruitment
International Endodontic Journal · 2025
DOI: 10.1111/iej.14198 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Endodontic Journal, 2025. Verfasst von Li Cui und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Stomatology, Stomatological Hospital, Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Osteogenesis, Mesenchymal Stem Cells, Cell Differentiation, Methyltransferases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Guangdong Provincial Science and Technology Project Foundation, Science Research Cultivation Program of Stomatological Hospital, Southern Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Aim
Effective control of mesenchymal stem cell (MSC) differentiation towards osteogenic lineages is fundamental for bone regeneration. This study elucidates the regulatory role of methyltransferase like 7A (METTL7A) in the osteogenic differentiation of MSCs. Methodology Alkaline phosphatase staining, Alizarin Red S staining, western blotting, and in vivo studies were conducted to determine the effects of METTL7A depletion or overexpression on the osteogenic differentiation of various types of MSCs. Then the downstream signalling pathways regulated by METTL7A in MSCs were further investigated.
Results
Our findings indicate that METTL7A expression significantly increases during the osteogenic differentiation of MSCs. Furthermore, depletion of METTL7A hindered, whereas its overexpression enhanced, the osteogenic differentiation of MSCs. Mechanistically, METTL7A influences MSC osteogenic differentiation by activating the YAP1‐TEAD1 signalling pathway. It enhances YAP1 expression not only by stabilising YAP1 mRNA but also, crucially, by recruiting the eIF4F complex, thereby boosting the translation efficiency of YAP1 mRNA. Additionally, the YAP1/TEAD1 complex transcriptionally regulates METTL7A expression, creating a positive feedback loop that amplifies osteogenic differentiation.
Conclusions
Overall, our study uncovers a previously unknown molecular mechanism of MSC osteogenic differentiation and suggests that activating METTL7A could offer new avenues for enhancing bone regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Stomatology, Stomatological Hospital, Southern Medical University, Guangzhou, Guangdong, China.
- Division of Oral Biology and Medicine, School of Dentistry, University of California, Los Angeles, California, USA.
- Department of Dentistry, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
ORCID-Profile: Li Cui
Förderung
- Guangdong Provincial Science and Technology Project Foundation
- Science Research Cultivation Program of Stomatological Hospital, Southern Medical University
- National Natural Science Foundation of China
- Young Top-notch Talent of Pearl River Talent Plan
Zitieren
APA
Cui, L., Mai, Z., Lu, Y., Zheng, J., Lin, P., Chen, X., Zheng, Y., Lin, Y., Guo, B., & Zhao, X. (2025). Laboratory investigation of METTL7A driving MSC osteogenic differentiation through YAP1 translation enhancement via eIF4F recruitment. International Endodontic Journal. https://doi.org/10.1111/iej.14198
Vancouver
Cui L, Mai Z, Lu Y, Zheng J, Lin P, Chen X, et al. Laboratory investigation of METTL7A driving MSC osteogenic differentiation through YAP1 translation enhancement via eIF4F recruitment. International Endodontic Journal. 2025. doi:10.1111/iej.14198
BibTeX
@article{Cui2025,
author = {Cui, Li and Mai, Zizhao and Lu, Ye and Zheng, Jiarong and Lin, Pei and Chen, Xu and Zheng, Yucheng and Lin, Yunfan and Guo, Bing and Zhao, Xinyuan},
title = {Laboratory investigation of METTL7A driving MSC osteogenic differentiation through YAP1 translation enhancement via eIF4F recruitment},
journal = {International Endodontic Journal},
year = {2025},
doi = {10.1111/iej.14198}
}
EUVIMED